Debt-to-equity of Inhibitor Therapeutics, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Inhibitor Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Inhibitor Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 325%, a 340% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Inhibitor Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 325% +251% +340% 30 Sep 2025
Q2 2025 176% +112% +177% 30 Jun 2025
Q1 2025 119% +64% +115% 31 Mar 2025
Q4 2024 91% +43% +88% 31 Dec 2024
Q3 2024 74% +30% +69% 30 Sep 2024
Q2 2024 63% -9.1% -13% 30 Jun 2024
Q1 2024 55% -126% -69% 31 Mar 2024
Q4 2023 49% +506% 31 Dec 2023
Q3 2023 44% +145% 30 Sep 2023
Q2 2023 73% +174% 30 Jun 2023
Q1 2023 182% +284% 31 Mar 2023
Q4 2022 -458% -355% -344% 31 Dec 2022
Q3 2022 -101% +2.2% +2.1% 30 Sep 2022
Q2 2022 -102% +2% +2% 30 Jun 2022
Q1 2022 -102% +2% +1.9% 31 Mar 2022
Q4 2021 -103% +3.5% +3.3% 31 Dec 2021
Q3 2021 -104% +9.7% +8.6% 30 Sep 2021
Q2 2021 -104% +24% +19% 30 Jun 2021
Q1 2021 -104% +53% +34% 31 Mar 2021
Q4 2020 -107% +87% +45% 31 Dec 2020
Q3 2020 -113% +157% +58% 30 Sep 2020
Q2 2020 -128% +28% +18% 30 Jun 2020
Q1 2020 -158% -74% -90% 31 Mar 2020
Q4 2019 -194% -142% -273% 31 Dec 2019
Q3 2019 -270% -229% -554% 30 Sep 2019
Q2 2019 -157% -15% -10% 30 Jun 2019
Q1 2019 -83% -160% -208% 31 Mar 2019
Q4 2018 -52% -82% -274% 31 Dec 2018
Q3 2018 -41% -52% -489% 30 Sep 2018
Q2 2018 -142% -152% -1463% 30 Jun 2018
Q1 2018 77% +67% +635% 31 Mar 2018
Q4 2017 30% +15% +101% 31 Dec 2017
Q3 2017 11% -19% -64% 30 Sep 2017
Q2 2017 10% -33% -76% 30 Jun 2017
Q1 2017 10% -64% -86% 31 Mar 2017
Q4 2016 15% -57% -79% 31 Dec 2016
Q3 2016 29% -50% -63% 30 Sep 2016
Q2 2016 44% 30 Jun 2016
Q1 2016 75% 31 Mar 2016
Q4 2015 72% 31 Dec 2015
Q3 2015 80% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.